Wells Fargo
INTS icon

Wells Fargo’s Intensity Therapeutics INTS Stock Holding History

Wells Fargo’s Portfolio INTS Stock Details INTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.18K Buy
+200
New +$1.63K ﹤0.01% 6319
2024
Q4 		– Sell
-138
Closed -$13.2K – 7128
2024
Q3 		$13.2K Hold
138
– – ﹤0.01% 5731
2024
Q2 		$16.9K Buy
138
+39
+39% +$4.42K ﹤0.01% 5626
2024
Q1 		$12.9K Hold
99
– – ﹤0.01% 5693
2023
Q4 		$21.3K Hold
99
– – ﹤0.01% 5623
2023
Q3 		$9.85K Buy
+99
New +$13.7K ﹤0.01% 5812

Other funds holding INTS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.18B AUM 18.43% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo's INTS Position: Q1 2026 in Review

Wells Fargo opened a new position in Intensity Therapeutics (INTS) in Q1 2026: 200 shares worth $1.18K. The stake represents ﹤0.01% of the portfolio and ranks #6319 among its holdings. This is a return to the name: Wells Fargo previously reported a position in INTS as recently as Q3 2024.

Wells Fargo first reported a position in INTS in Q3 2023 and has held it in 6 quarters since. The position peaked at $21.3K in Q4 2023. 13 funds tracked by Wall St. Rank hold INTS as of Q1 2026.

  • Wells Fargo held 200 shares of Intensity Therapeutics worth $1.18K as of Q1 2026.
  • Intensity Therapeutics was a new Wells Fargo position in Q1 2026.
  • Intensity Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6319 holding.
  • Wells Fargo first reported a position in Intensity Therapeutics in Q3 2023 and has held it in 6 quarters since.
  • Wells Fargo's Intensity Therapeutics position peaked at $21.3K in Q4 2023.
  • 13 funds tracked by Wall St. Rank held Intensity Therapeutics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.